ABIN1584589

antibody from antibodies-online

Targeting: IGF2 C11orf43, FLJ44734, IGF-II

Western blot (Data presented on provider website)

ELISA (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

ABIN1584589

Provider

antibodies-online

Product name

anti-IGF2 (N-Term) antibody

Antibody type

Polyclonal

Antigen

KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human IGF2.

Description

Antibody was purified by Protein-G affinity chromatography.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Epitope

N-Term

Vial size

0.1 mg

Concentration

1 mg/mL

Storage

-20°C

Handling

Minimize freeze-thaw cycles.

References

Submitted references

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, Blaney SM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jan 20;30(3):256-62

---

Induction of insulin-like growth factor 2 expression in a mesenchymal cell line co-cultured with an ameloblast cell line.

Matsumoto A, Harada H, Saito M, Taniguchi A
In vitro cellular & developmental biology. Animal 2011 Oct;47(9):675-80

---

[The fight against doping: international and national efforts as exemplified by the Convention of the Council of Europe and the doping regulations of the Swiss National Association for Sports].

Kamber M
Schweizerische Zeitschrift fur Sportmedizin 1990 Sep;38(2):101-6